Ablynx gets tangled up in partnerships with Big Pharma companies

By Joachim Eeckhout

The Belgium-based company is leading more than 20 pre-clinical and clinical programmes with several partners to put the Nanobody technology on the market. Companies such as AbbVie, Boehringer Ingelheim, Eddingpharm, Merck & Co, Merck Serono and Novartis are part of Ablynx’s dream team. Ablynx is a biotech company developing Nanobodies. Lire la suite

Source:: Labiotech

Les commentaires sont clos.